Celltrion

This study tested whether adding pioglitazone to the standard two-drug therapy (metformin and empagliflozin) helps people with type 2 diabetes who still have high blood sugar. Over 600 adults took part in this Phase 3 trial. The main goal was to see if the extra drug lowers HbA1c…

This study tested an injectable drug called CT-P13 in 192 adults with moderate-to-severe rheumatoid arthritis. The goal was to see if it reduces joint pain and swelling better than a placebo. Participants received either the drug or a dummy shot, and researchers measured improvem…

This Phase 3 trial tested whether taking two blood pressure medications (AZM and AML) together works better than taking either one alone. About 890 adults with mild-to-moderate high blood pressure took part. The study lasted 8 weeks and compared different doses of the combination…

This Phase 1 trial tests two experimental drugs (L03RD1 and L03RD2) in 48 healthy adults to see how safe they are and how the body processes them. Participants take the drugs alone or together in a single dose. The study does not aim to treat diabetes, but to gather information f…

This study tests if giving the drug CT-P52 with an auto-injector works as well as using a pre-filled syringe. It involves 218 healthy men aged 19 to 55. The goal is to see how the drug moves through the body and if it is safe with both methods.

This phase 1 trial compared a single dose of CT-P6, a biosimilar of the cancer drug trastuzumab, to the approved Herceptin in 200 healthy men. The goal was to see if the two drugs behave similarly in the body and have comparable safety. Results will help determine if CT-P6 can be…

This study tested two different devices for giving a single dose of the biologic drug CT-P43: an auto-injector and a pre-filled syringe. It involved 162 healthy men aged 19 to 55. The goal was to see if the two methods deliver the drug similarly into the body and to check for any…

This early-phase study tested how a new combination of two experimental drugs (L03RD1 and L03RD2) is processed by the body and whether it is safe. It involved 49 healthy adults aged 19-55. The goal was to measure drug levels in the blood and check for side effects, not to treat d…

This early-stage study tested a new combination pill (CTL02) that contains two diabetes drugs (alogliptin and empagliflozin) in a single tablet. Forty healthy adults received either the combo pill or the two drugs separately to compare safety and how the body processes them. The …